These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24427762)

  • 61. Formulation Approach that Enables the Coating of a Stable Influenza Vaccine on a Transdermal Microneedle Patch.
    Ameri M; Ao Y; Lewis H
    AAPS PharmSciTech; 2021 Jun; 22(5):175. PubMed ID: 34114100
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles.
    Hsueh KJ; Chen MC; Cheng LT; Lee JW; Chung WB; Chu CY
    Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():78-87. PubMed ID: 28131383
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Enhanced immunity in intradermal vaccination by novel hollow microneedles.
    Ogai N; Nonaka I; Toda Y; Ono T; Minegishi S; Inou A; Hachiya M; Fukamizu H
    Skin Res Technol; 2018 Nov; 24(4):630-635. PubMed ID: 29707828
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine.
    Weldon WC; Zarnitsyn VG; Esser ES; Taherbhai MT; Koutsonanos DG; Vassilieva EV; Skountzou I; Prausnitz MR; Compans RW
    PLoS One; 2012; 7(7):e41501. PubMed ID: 22848514
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
    Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine.
    Hong X; Wei L; Wu F; Wu Z; Chen L; Liu Z; Yuan W
    Drug Des Devel Ther; 2013; 7():945-52. PubMed ID: 24039404
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Microneedle and mucosal delivery of influenza vaccines.
    Kang SM; Song JM; Kim YC
    Expert Rev Vaccines; 2012 May; 11(5):547-60. PubMed ID: 22697052
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles.
    Song JM; Kim YC; Barlow PG; Hossain MJ; Park KM; Donis RO; Prausnitz MR; Compans RW; Kang SM
    Antiviral Res; 2010 Nov; 88(2):244-7. PubMed ID: 20851715
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
    Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
    J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.
    Chu LY; Ye L; Dong K; Compans RW; Yang C; Prausnitz MR
    Pharm Res; 2016 Apr; 33(4):868-78. PubMed ID: 26620313
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Formulation of microneedles coated with influenza virus-like particle vaccine.
    Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR
    AAPS PharmSciTech; 2010 Sep; 11(3):1193-201. PubMed ID: 20676947
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Delivery systems for intradermal vaccination.
    Kim YC; Jarrahian C; Zehrung D; Mitragotri S; Prausnitz MR
    Curr Top Microbiol Immunol; 2012; 351():77-112. PubMed ID: 21472533
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Detachable-dissolvable-microneedle as a potent subunit vaccine delivery device that requires no cold-chain.
    Phoka T; Thanuthanakhun N; Visitchanakun P; Dueanphen N; Wanichwecharungruang N; Leelahavanichkul A; Palaga T; Ruxrungtham K; Wanichwecharungruang S
    Vaccine X; 2023 Dec; 15():100398. PubMed ID: 37920235
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Silk Fibroin Microneedles for Transdermal Vaccine Delivery.
    Stinson JA; Raja WK; Lee S; Kim HB; Diwan I; Tutunjian S; Panilaitis B; Omenetto FG; Tzipori S; Kaplan DL
    ACS Biomater Sci Eng; 2017 Mar; 3(3):360-369. PubMed ID: 33465933
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity.
    Ma Y; Tao W; Krebs SJ; Sutton WF; Haigwood NL; Gill HS
    Pharm Res; 2014 Sep; 31(9):2393-403. PubMed ID: 24623480
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine.
    Zuckermann FA; Martin S; Husmann RJ; Brandt J
    Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Recent Advances in Microneedle Platforms for Transdermal Drug Delivery Technologies.
    Mdanda S; Ubanako P; Kondiah PPD; Kumar P; Choonara YE
    Polymers (Basel); 2021 Jul; 13(15):. PubMed ID: 34372008
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The success of microneedle-mediated vaccine delivery into skin.
    Marshall S; Sahm LJ; Moore AC
    Hum Vaccin Immunother; 2016 Nov; 12(11):2975-2983. PubMed ID: 27050528
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
    Wang T; Wang N
    Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Design, characterization, and modeling of a chitosan microneedle patch for transdermal delivery of meloxicam as a pain management strategy for use in cattle.
    Castilla-Casadiego DA; Carlton H; Gonzalez-Nino D; Miranda-Muñoz KA; Daneshpour R; Huitink D; Prinz G; Powell J; Greenlee L; Almodovar J
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111544. PubMed ID: 33255096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.